In addition, single nucleotide polymorphisms in the BIM gene have been associated with risk of developing follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL), and chronic lymphocytic leukemia (CLL) (13). This evidence concerns the gene BCL2L11 and diffuse large B-cell lymphoma.